Core Viewpoint - A class action lawsuit has been announced against Snowflake Inc. for securities fraud, involving purchasers of Class A common stock between June 27, 2023, and February 28, 2024, with the opportunity for investors to serve as lead plaintiffs [1]. Group 1: Lawsuit Details - The lawsuit claims that during the class period, Snowflake's management made positive statements about business performance while failing to disclose significant negative impacts on consumption and revenues due to product efficiency gains and pricing strategies [1]. - Investors who purchased Snowflake Class A common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - The Rosen Law Firm, which is leading the lawsuit, has a strong track record in securities class actions, having recovered hundreds of millions of dollars for investors in the past [1]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [1]. - A lead plaintiff must be appointed by April 27, 2026, to represent the interests of the class members in the litigation [1]. - Until a class is certified, investors are not represented by counsel unless they retain one, and they may choose to remain absent from the class [1].

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Corcept Therapeutics Incorporated ("Corcept†or the "Company†) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the "Class Period†). Corcept investors have until April 21, 2026 to file a lead plaintiff motion. The complaint filed in this class action alleges that throughout the Class Period, Defendants made materiall ...

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.  The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an ...

SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, both dates inclusive (the “Class Period”), have until April 21, 2026 to seek appointment as lead plaintiff of the Corcept class action lawsuit. Captioned Allegheny County Employees’ Retirement System v. Corcept Therapeutics Incorporated, No. 26-cv-01525 (N.D. Cal.), the Corcept cla ...

Core Viewpoint - The PayPal class action lawsuit alleges that the company and certain executives misled investors regarding the company's revenue outlook and growth potential during the Class Period, leading to significant financial losses for shareholders [3][4]. Group 1: Class Action Details - The lawsuit is titled Goodman v. PayPal Holdings, Inc., and it allows purchasers of PayPal common stock between February 25, 2025, and February 2, 2026, to seek appointment as lead plaintiff by April 20, 2026 [1]. - The lawsuit claims that PayPal's executives created a false impression of reliable growth projections while downplaying risks associated with seasonality and macroeconomic factors [3]. Group 2: Financial Performance and Impact - On February 3, 2026, PayPal announced disappointing financial results for Q4 and the full fiscal year 2025, which included a decline in Branded Checkout performance and the withdrawal of previously set 2027 financial targets [4]. - Following the announcement, PayPal's stock price fell by more than 20%, reflecting investor reaction to the negative news and the transition of CEO James Alexander Chriss [4]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased PayPal common stock during the Class Period to seek lead plaintiff status, which involves directing the class action lawsuit on behalf of all class members [5]. - The lead plaintiff can choose a law firm to represent them, and participation as lead plaintiff does not affect an investor's ability to share in any potential recovery [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [6]. - The firm has a strong track record, recovering a total of $8.4 billion for investors over the past five years, making it one of the largest plaintiffs' firms globally [6].

purchasers or acquirers of Richtech Robotics Inc. (NASDAQ: RR) publicly traded...][More Releases From This Source]## Explore[Banking & Financial Services][News Releases in Similar Topics]---- -- Kyndryl Holdings, Inc. Securities Class Action Lawsuit Filed; Lead Plaintiff Deadline April 13, 2026 [Accessibility Statement] Skip NavigationSAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- The law firm of [Robbins Geller Rudman & Dowd LLP] announces that purchasers or acquirers of Kyndryl Holdings, Inc. (NYSE: KD) publicl ...

Ademi LLP Investigates Claims of Securities Fraud against Driven Brands Holdings Inc. [Accessibility Statement] Skip NavigationMILWAUKEE, Feb. 25, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Driven Brands (NASDAQ: DRVN). The investigation results from inaccurate statements Driven Brands may have made regarding its financial statements, business operations and prospects.Click [here] to join our investigation or to obtain additional information, or contact us at [[ ...

Core Viewpoint - A class action lawsuit has been filed against Navan, Inc. for violations of federal securities laws, alleging that the company made false and misleading statements regarding its financial needs post-IPO [1][4]. Group 1: Lawsuit Details - The Schall Law Firm is representing investors who purchased Navan's securities related to its IPO on October 31, 2025, and encourages them to contact the firm before April 24, 2026 [2]. - The lawsuit claims that Navan misled investors by not disclosing the need for significant increases in sales and marketing expenditures to achieve growth in usage yield and Gross Booking Volume [4]. Group 2: Investor Impact - Investors suffered damages when the truth about Navan's financial requirements became known, indicating that the company's public statements were materially misleading during the IPO period [4].

SAN FRANCISCO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman is issuing an updated notice to investors in BellRing Brands, Inc. (NYSE: BRBR) regarding the March 23, 2026, lead plaintiff deadline accusing BellRing and certain of BellRing’s top executives of securities fraud. CLICK HERE TO SUBMIT YOUR BRBR LOSSES NOW The suit alleges Defendants misled investors about the true drivers of BellRing’s 2025 sales growth. The truth emerged over a series of disclosures revealin ...

Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit [Accessibility Statement] Skip NavigationLOS ANGELES, Feb. 25, 2026 /PRNewswire/ -- [The Law Offices of Frank R. Cruz] announces that investors with losses related to Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ: [INO]) have opportunity to lead the securities fraud class action lawsuit.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INOVIO PHARMACEUTICALS, INC. (INO), CLICK [HER ...